These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 32553631)
21. HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53. Yang D; Cheng D; Tu Q; Yang H; Sun B; Yan L; Dai H; Luo J; Mao B; Cao Y; Yu X; Jiang H; Zhao X Theranostics; 2018; 8(13):3517-3529. PubMed ID: 30026863 [TBL] [Abstract][Full Text] [Related]
22. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma. Yang Y; Zhu J; Zhang T; Liu J; Li Y; Zhu Y; Xu L; Wang R; Su F; Ou Y; Wu Q J Exp Clin Cancer Res; 2018 Mar; 37(1):65. PubMed ID: 29566713 [TBL] [Abstract][Full Text] [Related]
23. RNF115 promotes lung adenocarcinoma through Wnt/β-catenin pathway activation by mediating APC ubiquitination. Wu XT; Wang YH; Cai XY; Dong Y; Cui Q; Zhou YN; Yang XW; Lu WF; Zhang M Cancer Metab; 2021 Jan; 9(1):7. PubMed ID: 33509267 [TBL] [Abstract][Full Text] [Related]
24. SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21 Lv L; Zhou M; Zhang J; Liu F; Qi L; Zhang S; Bi Y; Yu Y FEBS Open Bio; 2020 Jan; 10(1):135-146. PubMed ID: 31729835 [TBL] [Abstract][Full Text] [Related]
25. LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability. Zhang Y; Zhang Y; Xu H Gene; 2019 Sep; 712():143963. PubMed ID: 31279706 [TBL] [Abstract][Full Text] [Related]
26. Reduced CENPU expression inhibits lung adenocarcinoma cell proliferation and migration through PI3K/AKT signaling. Li J; Wang ZG; Pang LB; Zhang RH; Wang YY Biosci Biotechnol Biochem; 2019 Jun; 83(6):1077-1084. PubMed ID: 30849291 [TBL] [Abstract][Full Text] [Related]
27. Multifaceted Roles of the E3 Ubiquitin Ligase RING Finger Protein 115 in Immunity and Diseases. Wang MX; Liuyu T; Zhang ZD Front Immunol; 2022; 13():936579. PubMed ID: 35844553 [TBL] [Abstract][Full Text] [Related]
28. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction. Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825 [TBL] [Abstract][Full Text] [Related]
29. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex. Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554 [TBL] [Abstract][Full Text] [Related]
30. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients. Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619 [TBL] [Abstract][Full Text] [Related]
31. Goto D; Komeda K; Uwatoko N; Nakashima M; Koike M; Kawai K; Kodama Y; Miyazawa A; Tanaka I; Hase T; Morise M; Hasegawa Y; Kawabe T; Sato M Cancer Invest; 2020 Apr; 38(4):240-249. PubMed ID: 32212938 [TBL] [Abstract][Full Text] [Related]
32. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma. Goeman F; De Nicola F; Scalera S; Sperati F; Gallo E; Ciuffreda L; Pallocca M; Pizzuti L; Krasniqi E; Barchiesi G; Vici P; Barba M; Buglioni S; Casini B; Visca P; Pescarmona E; Mazzotta M; De Maria R; Fanciulli M; Ciliberto G; Maugeri-Saccà M J Thorac Oncol; 2019 Nov; 14(11):1924-1934. PubMed ID: 31323387 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer. Ujiie H; Kato T; Lee D; Hu HP; Fujino K; Kaji M; Kaga K; Matsui Y; Yasufuku K Int J Oncol; 2017 Jun; 50(6):2154-2170. PubMed ID: 28498455 [TBL] [Abstract][Full Text] [Related]
34. CacyBP promotes the development of lung adenocarcinoma by regulating OTUD5. Bai M; Lu K; Che Y; Fu L Carcinogenesis; 2024 Aug; 45(8):595-606. PubMed ID: 38558058 [TBL] [Abstract][Full Text] [Related]
35. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma. Song YH; Zhang CQ; Chen FF; Lin XY Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375 [TBL] [Abstract][Full Text] [Related]
36. Combinatory inhibition of TRIM65 and MDM2 in lung cancer cells. Chen G; Zhou T; Liu Y; Yu Z Biochem Biophys Res Commun; 2018 Nov; 506(3):698-702. PubMed ID: 30454706 [TBL] [Abstract][Full Text] [Related]
37. BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion. Shen C; Wang Y; Wei P; Du X BMC Cancer; 2016 Aug; 16(1):670. PubMed ID: 27553041 [TBL] [Abstract][Full Text] [Related]
38. Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma. Kim KH; Chung C; Kim JM; Lee D; Cho SY; Lee TH; Cho HJ; Yeo MK BMC Cancer; 2019 Aug; 19(1):804. PubMed ID: 31412817 [TBL] [Abstract][Full Text] [Related]
39. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines. Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369 [TBL] [Abstract][Full Text] [Related]
40. A Method for the Establishment of Human Lung Adenocarcinoma Patient-Derived Xenografts in Mice. Lundy J; Jenkins BJ; Saad MI Methods Mol Biol; 2021; 2279():165-173. PubMed ID: 33683693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]